What is the benefit of digoxin initiation in hospitalized patients with heart failure with reduced ejection fraction and heart failure with preserved ejection fraction and atrial fibrillation? In this video, Dr. Joseph S. Alpert, AJM editor-in-chief, explains the new research findings in “Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation” by Singh et al in the December 2020 issue of AJM, available at AmJMed.com.
